Identification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.

Overview

• This research identified three new linear B-cell epitopes on the VP7 protein of African horse sickness virus (AHSV) using monoclonal antibodies.
• The findings enhance understanding of immune recognition of AHSV VP7 and provide insights for developing diagnostic tools and vaccines.

Background

• African horse sickness (AHS): A severe infectious viral disease affecting equines, caused by African horse sickness virus (AHSV).
• AHSV VP7 protein: A group-specific protein that is highly conserved across all AHSV serotypes, making it a promising candidate for serological diagnosis and vaccine development.
• Knowledge gap: Prior to this study, the exact B-cell epitopes on VP7—parts of the protein recognized by the immune system—were not clearly identified.

Objectives

• To express and purify the recombinant VP7 protein of AHSV.
• To generate monoclonal antibodies (mAbs) against VP7 by mouse immunization.
• To identify specific linear B-cell epitopes on VP7 recognized by these monoclonal antibodies.
• To evaluate the conservation of these epitopes among different AHSV serotypes and their specificity compared to related orbiviruses.

Methodology

• Recombinant protein production: VP7 protein from AHSV was expressed in Escherichia coli in a soluble form and purified.
• Immunization and mAb generation: Mice were immunized with the purified VP7, and hybridoma technology was used to produce and screen monoclonal antibodies targeting VP7.
• Monoclonal antibody screening: Four mAbs—named 4B5, 3G10, 3D7, and 4D6—were isolated through clonal purification and immunological assays.
• Epitope mapping: A series of truncated overlapping peptides fused to glutathione S-transferase (GST) were expressed to pinpoint the exact amino acid sequences (linear epitopes) recognized by each mAb.
• Sequence analysis: Multiple sequence alignment was performed to check the conservation of identified epitopes among AHSV serotypes and their presence or absence in related orbiviruses like bluetongue and epidemic hemorrhagic disease viruses.

Findings

• Epitope identification: Three distinct linear B-cell epitopes were discovered:
  • Epitope recognized by mAb 4B5: amino acid motif “VQTGRYAGA”
  • Epitope recognized by mAb 3G10: amino acid motif “RYYVPQGRT”
  • Epitope recognized by mAbs 3D7 and 4D6: shared amino acid motif “QPINPPIFP”
• Conservation: These epitopes were highly conserved across multiple AHSV serotypes, suggesting their importance in immune recognition of the virus.
• Specificity: The epitopes were not conserved in related orbiviruses such as bluetongue virus and epidemic hemorrhagic disease virus, indicating these epitopes are specific to AHSV.

Implications

• The identification of these novel B-cell epitopes can help design better serological diagnostic tests that are AHSV-specific, enhancing accuracy in detecting AHS infections.
• These epitopes may serve as targets for developing epitope-based vaccines, potentially improving protective immunity against diverse AHSV serotypes.
• The findings expand the understanding of AHSV immunogenic structure, assisting future research into virus-host interactions and immunodiagnostics.

Conclusion

• This study successfully identified and characterized three novel linear B-cell epitopes on the VP7 protein of African horse sickness virus using monoclonal antibodies.
• The newly mapped epitopes are conserved in AHSV but distinct from related orbiviruses, making them valuable for specific diagnosis and vaccination strategies.